Metformin (generic), Glucophage

Bookmark

Add to MyYahoo RSS

Metformin (generic), Glucophage News

News on Metformin (generic), Glucophage continually updated from thousands of sources around the net.

Friday Aug 22 | Diabetes Self Management

New Approach for Neuropathy Pain?

Pain from diabetic neuropathy can be debilitating for people who have the condition, and it can be difficult to treat, with only an estimated 40% to 60% of those affected achieving partial relief .

Comment?

Related Topix: Diabetic Neuropathy, Health, Diabetes, Vitamin B12, Supplement

Wed Aug 20, 2014

BioSpace

Boston Therapeutics, Inc. Completes Enrollment Of Patients With Type ...

Boston Therapeutics, Inc. , a developer of complex carbohydrate therapeutics to treat diabetes, has completed enrollment of its Phase IIb clinical study on BTI-320 in the United States.

Comment?

Related Topix: Medicine, Diabetes, Health, Insulin (generic), Humulin, Novolin

Freshnews

NuSirt Biopharma Launches First Clinical Trial

NuSirt Biopharma , Inc., is initiating a clinical trial with a goal of demonstrating whether the company's patented technology may enhance the ability of a common Type 2 diabetes medication, metformin, to control blood sugar.

Comment?

Related Topix: Medicine, Health, Diabetes

Tue Aug 19, 2014

Diabetes Self Management

Metformin Study Currently Recruiting

If you have Type 2 diabetes , you may be interested in a multisite study that is currently recruiting participants to evaluate the effectiveness of an extended-release version of the oral diabetes drug metformin versus the immediate-release version of the medicine.

Comment?

Related Topix: Medicine, Health, Diabetes

Fri Aug 15, 2014

Diabetes Self Management

New Metformin Combo Drug Approved for Type 2 Diabetes

On August 8, the U.S. Food and Drug Administration approved the oral combination medicine canagliflozin/metformin for Type 2 diabetes .

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Thu Aug 14, 2014

Prostate Cancer and Prostatic Diseases

A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer

Prostate Cancer and Prostatic Disease 17, 252–258; doi:10.1038/pcan.2014.20; published online 27 May 2014 Correspondence: Dr AM Joshua, Division of Medical Oncology and Hematology, 610 University Avenue, Room 5-101, Toronto, ON, Canada M5G2M9.

Comment?

Related Topix: Medicine, Prostate Cancer, Health, Oncology, Hematology, Insulin (generic), Humulin, Novolin

Wed Aug 13, 2014

Battle Diabetes

Metformin could make you live longer, study says

Patients who are being treated with metformin for type 2 diabetes might live longer than other people with the condition who aren't taking the drug, according to researchers at Cardiff University.

Comment?

Related Topix: Medicine, Health, Diabetes

Mon Aug 11, 2014

P&T Community

FDA Approves Invokamet (Canagliflozin/Metformin) for Diabetes Patients

The FDA has approved Invokamet , a fixed-dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type-2 diabetes.

Comment?

Related Topix: Medicine, Diabetes, Health

Sun Aug 10, 2014

Scientific Blogging

Invokamet For Treatment Of Type 2 Diabetes Approved

The U.S. Food and Drug Administration has approved INVOKAMETa , a fixed-dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes.

Comment?

Related Topix: Medicine, Diabetes, Health, Food and Drug Administration

Medical Daily

Diabetes Drug, Metformin, May Increase Lifespan Of Non-Diabetics; The ...

An inexpensive and widely used medication for those with type 2 diabetes goes beyond its ability to control sugar levels and has been shown to slow down the aging process in non-diabetics.

Comment?

Related Topix: Medicine, Health, Diabetes

Sat Aug 09, 2014

Cardiovascular Diabetology

Association of metformin with lower atrial fibrillation risk among...

BackgroundAtrial fibrillation , an inflammatory process involving arrhythmia, is associated with severe morbidity and mortality and commonly seen in patients with diabetes mellitus .

Comment?

Related Topix: Medicine, Health, Diabetes

Fri Aug 08, 2014

Sys-Con Media

U.S. FDA Approves INVOKAMETa (canagliflozin/metformin HCl) for the...

INVOKAMETa provides the clinical attributes of INVOKANAA , the first sodium glucose co-transporter 2 inhibitor available in , together with metformin, which is commonly prescribed early in the treatment of type 2 diabetes.

Comment?

Related Topix: Medicine, Food and Drug Administration, Diabetes, Insulin (generic), Humulin, Novolin

BioSpace

Cardiff University Study Shows Type 2 Diabetics Can Live Longer Than People Without The Disease

Study Shows Type 2 Diabetics Can Live Longer Than People Without The Disease A commonly prescribed diabetes drug could offer surprising health benefits to non-diabetics Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown.

Comment?

Related Topix: Medicine, Diabetes, Health

Pharmaceutical Online

Eli Lilly Updates Jentadueto Label To Include Phase 4 Data

Eli Lilly announced that it has successfully updated the label of its Type 2 diabetes drug Jentadueto to include the latest data from a Phase IV trial showing significant blood glucose reductions.

Comment?

Related Topix: Medicine, Diabetes, Health, Healthcare Law, Law, Fasting

Thu Aug 07, 2014

CiteULike

Glycemic Management of Type 2 Diabetes Mellitus

N Engl J Med In New England Journal of Medicine, Vol. 366, No. 14. , pp. 1319-1327, doi:10.1056/nejmcp1013127 Key Clinical Points Glycemic Control in Type 2 Diabetes Mellitus Intensive glycemic control reduces the risk of microvascular complications of type 2 diabetes, but the effect of strict glycemic control on the risk of macrovascular disease ... (more)

Comment?

Related Topix: Medicine, Health, Diabetes

Daily Mail

Diabetes drug that could help us all live longer: Doctors say it could also stave off cancer

Research suggests metformin, which controls glucose levels, may also stave off cardiovascular disease and cancer - whether someone has diabetes or not.

Comment?

Related Topix: Medicine, Diabetes, Health, Mathematics, Science

IcNetwork

So just why are some patients with Type 2 diabetes living longer than those without the condition?

Patients treated with a drug widely prescribed for Type 2 diabetes can live longer than people without the condition, a large-scale study involving more than 180,000 people has shown.

Comment?

Related Topix: Medicine

Mon Aug 04, 2014

Battle Diabetes

Reducing blood sugar works best with drug duo, study finds

The combined effects of metformin and SGLT2 inhibitors work best to help reduce blood sugar in diabetics more than one drug alone, report researchers in the journal Diabetes .

Comment?

Related Topix: Medicine, Health, Diabetes

Applied Clinical Trials

Type 2 diabetes: Jentadueto? (linagliptin and metformin...

Type 2 diabetes: Jentadueto? tablets label updated to include new data on blood glucose reductions in treatment-naive adults with high baseline A1C Type 2 diabetes: Jentadueto tablets label updated to include new data on blood glucose reductions in treatment-naive adults with high baseline A1C /PRNewswire/ -- The U.S. Prescribing Information for ... (more)

Comment?

Related Topix: Medicine, Diabetes, Health, Biotech, Eli Lilly, Healthcare Industry

Medical News

Metformin and SGLT2 inhibitors together reduce blood sugar levels

Metformin and SGLT2 inhibitors together reduce the blood sugar levels considerably more effectively than either drug alone.

Comment?

Related Topix: Medicine, Health, Diabetes

•••
•••
•••
•••
•••
•••
•••